Physician profile
Barbara Labban
NPI 1629228085
$429.73
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2021: $17.02 · 2022: $35.17 · 2023: $63.77 · 2024: $85.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.39 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $143.56 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $71.22 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.91 | 2023-2024 | |
| Akebia Therapeutics INC | $24.61 | 2024 | Vafseo |
| Calliditas Therapeutics US INC. | $23.36 | 2023 | Tarpeyo |
| Fresenius USA Marketing, INC. | $23.27 | 2024 | |
| Opko Pharmaceuticals, LLC | $19.85 | 2023 | Rayaldee |
| Genentech USA, INC. | $19.37 | 2019 | |
| Aurinia Pharma U.S., INC. | $17.02 | 2021 | |
| Vifor Pharma, INC. | $15.35 | 2019 | |
| Nxstage Medical, INC. | $14.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Labban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.